BIOCHEMISTRY ANALYZERS MARKET ANALYSIS

Biochemistry Analyzers Market, By Product Type (Semi-automatic biochemistry analyzers, Fully automatic biochemistry analyzers.), By Modality (Bench Top, Floor Standing), By End User (Hospitals, Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Contract Research Organizations Floor Standing), By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Published In : Apr 2023
Code : CMI1873
Pages :181
Formats :
Excel and PDF
Industry : Medical Devices

Leading Companies

Key market players are focusing on improvement in patient care by broadening access to high-quality test results. Thus global biochemistry analyzers market growth can be driven by an increase in product launches by the key market players over the forecast period. For instance, in November 2022, Roche, healthcare company, nnounced the cobas 5800 System, a compact, fully-automated molecular laboratory instrument that offers a flexible, PCR testing solution that aids clinicians in the diagnosis of infectious diseases. The cobas 5800 is designed to provide optimized workflow efficiencies, simplicity, and timely results that can benefit labs of all sizes.

Major players operating in the global biochemistry analyzers market include Roche Diagnostics GmbH, Siemens AG, Beckman Coulter Inc., Abbott Diagnostics Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Hologic, Inc., Randox Laboratories Ltd., Awareness Technology, Inc., Transasia Biomedicals Ltd., Nova Biomedical Corp.